LSD

• 1. The Accidental Discovery

  ›

  On the 16th of November 1938, Swiss chemist Albert Hofmann synthesized lysergic acid diethylamide at Sandoz Laboratories in Basel. This was the twenty-fifth compound he created from lysergic acid while searching for a respiratory stimulant. The molecule remained dormant until five years later when Hofmann accidentally absorbed a small amount through his skin. He experienced dizziness and visual distortions that led him to ingest 250 micrograms of the substance on the 19th of April 1943. This intentional trial revealed effects far stronger than any ergot alkaloid previously known. Hofmann described the experience as intense mental changes that included altered perception of time and space.

• 2. Psychiatry And Early Research

  ›

  Sandoz Laboratories introduced LSD as a psychiatric drug named Delysid in 1947. They distributed the substance free to researchers hoping to find therapeutic applications. By 1960, psychiatrists had tried the drug in every type of mental disorder including schizophrenia and alcoholism. Humphry Osmond pioneered its use for treating alcoholism with promising results during the 1950s. The Central Intelligence Agency began Project MKUltra in the 1950s to study psychoactive substances for interrogation purposes. They administered LSD to unwitting subjects including military personnel and prostitutes without their knowledge. The Rockefeller Commission report revealed these experiments in 1975 after CIA director Richard Helms destroyed many documents in 1973. Sandoz stopped production and distribution in 1965 when patents expired.

• 3. Counterculture And Cultural Impact

  ›

  The youth countercultures in California adopted hallucinogenic drugs by the mid-1960s. Owsley Stanley established the first major underground LSD factory in San Francisco around this time. The Merry Pranksters organized Acid Tests involving consumption accompanied by light shows and improvised music. Tom Wolfe documented these cross-country trips in his book The Electric Kool-Aid Acid Test published in 1968. The Psychedelic Shop opened in Haight-Ashbury in January 1966 to promote safe use of the substance. Michael Hollingshead founded the World Psychedelic Center in Chelsea London in 1965. Bands like the Grateful Dead and Jefferson Airplane became central to the culture. The Beatles released Sgt. Pepper's Lonely Hearts Club Band featuring psychedelic-themed artwork influenced by the drug. Possession became illegal in the United States on the 24th of October 1968.

• 4. Molecular Binding And Brain Activity

  ›

  LSD exerts its effects primarily through high-affinity binding to serotonin receptors especially the 5-HT2A receptor. It also binds to dopamine D2-like receptors at lower affinity levels. Neuroimaging studies show that the drug changes cortical functional architecture spatially overlapping with serotonergic receptor distribution. Increased connectivity appears in regions with high expression of 5-HT2A receptors while activity decreases in areas dense with 5-HT1A receptors. The drug reduces oscillatory power in the brain's default mode network and flattens neural hierarchy. A crystal structure reveals an extracellular loop forms a lid over the diethylamide end trapping LSD in the binding pocket. This explains the slow rate of unbinding from serotonin receptors lasting hours despite rapid clearance from blood.

• 5. Safety Profile And Toxicity Data

  ›

  No fatal human overdoses have been documented for typical recreational doses between 50 and 250 micrograms. Animal studies suggest the lethal dose is approximately 100 milligrams which equals about one thousand times the usual recreational amount. A 2010 study ranked LSD as significantly less harmful than alcohol placing it near the bottom of twenty drugs assessed. Common adverse effects include agitation tachycardia hallucinations and pupil dilation occurring in 2.4 to 42 percent of cases. Serious toxicity remains infrequent with fever appearing in 3.8 percent of exposures reported to poison control centers. Hallucinogen persisting perception disorder causes flashbacks where individuals re-experience subjective effects after the drug wears off. These occur intermittently or chronically causing distress in rare cases ranging from 1 in 20 users to 1 in 50,000 depending on severity type.

• 6. Modern Medical Resurgence

  ›

  Research on LSD declined due to cultural controversies by the 1960s but has resurged since 2009. The last FDA approved study of LSD in patients ended in 1980 while a study in healthy volunteers occurred in the late 1980s. Legally approved psychiatric use continued in Switzerland until 1993. In November 2020 Oregon became the first US state to decriminalize possession of small amounts following Ballot Measure 110. The United States Food and Drug Administration designated LSD code name MM120 as a breakthrough therapy for generalized anxiety disorder in 2024. A meta analysis concluded that a single dose was effective at reducing alcohol consumption in people suffering from alcoholism. Current studies show positive preliminary results for treating depression and anxiety despite no legally approved medical uses existing today.